Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy

Part of paid clinical trials in Cleveland, Ohio.

Sponsor
The Cleveland Clinic
Study ID
NCT04310241
Status
Recruiting
Apply to this trial

Conditions

  • Amblyopia
  • Strabismus

Eligibility Criteria

Sex
ALL
Age
6 Months - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • Patching therapy, Glasses — BEHAVIORAL
    Patching, glasses and strabismus surgery are commonly employed measures in treatment of amblyopia and strabismus.

Study Details

Amblyopia and strabismus are characterized by a reduction in visual acuity, contrast sensitivity, grating acuity, vernier acuity, reading difficulties and binocular visual function deficits. Treated patients have residual visual function deficits. The purpose of the current study is to quantify various visual functions in amblyopic and strabismic participants at baseline, during and at the completion of treatment.

Key Dates

Start date
Feb 21, 2020
Status verified
Mar 2026
Primary completion
Mar 12, 2027
Completion
Mar 12, 2027

Study Design

Enrollment
150 participants (estimated)

Arms

  • Arm: Control subjects
    Subjects who state they have no eye or neurologic problems or disease other than perhaps wearing glasses or contact lenses and upon review of medical history.
  • Arm: Amblyopia
    Clinical diagnosis of amblyopia

Primary Outcome Measure

Visual Functions [ Time Frame: 0-3 years depending on duration of treatment ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Cleveland ClinicClevelandOhio44195
Fatema Ghasia, MD
216 318 7809
Kimberly Baynes
[email protected]
2164442566

Find similar trials in Cleveland, OH

By research site
Cleveland Clinic· Cleveland, OH

Related Studies